The Impact of CYP2D6 Genotyping on Tamoxifen Treatment

By Ferraldeschi Roberta   Newman William G.  

Pharmaceuticals, Vol. 3, Iss. 4, 2010-04 ,pp. : 1122-1138

MDPI

Access to resources Recommend Favorite

Prediction of Drug-Drug Interactions with Bupropion and Its Metabolites as CYP2D6 Inhibitors Using a Physiologically-Based Pharmacokinetic Model

By Xue Caifu   Zhang Xunjie   Cai Weimin  

Pharmaceutics, Vol. 10, Iss. 1, 2017-12 ,pp. : 1-1

MDPI

Access to resources Recommend Favorite

The Effects of H₂S on the Activities of CYP2B6, CYP2D6, CYP3A4, CYP2C19 and CYP2C9 in Vivo in Rat

By Wang Xianqin   Han Anyue   Wen Congcong   Chen Mengchun   Chen Xinxin   Yang Xuezhi   Ma Jianshe   Lin Guanyang  

International Journal of Molecular Sciences, Vol. 14, Iss. 12, 2013-12 ,pp. : 24055-24063

MDPI

Access to resources Recommend Favorite

Future Trends in the Pharmacogenomics of Brain Disorders and Dementia: Influence of APOE and CYP2D6 Variants

By Cacabelos Ramón   Fernández-Novoa Lucía   Martínez-Bouza Rocío   McKay Adam   Carril Juan C.   Lombardi Valter   Corzo Lola   Carrera Iván   Tellado Iván   Nebril Laura   Alcaraz Margarita   Rodríguez Susana   Casas Ángela   Couceiro Verónica   Álvarez Antón  

Pharmaceuticals, Vol. 3, Iss. 10, 2010-09 ,pp. : 3040-3100

MDPI

Access to resources Recommend Favorite

CYP 2D6 Binding Affinity Predictions Using Multiple Ligand and Protein Conformations

By Perić-Hassler Lovorka   Stjernschantz Eva   Oostenbrink Chris   Geerke Daan P.  

International Journal of Molecular Sciences, Vol. 14, Iss. 12, 2013-12 ,pp. : 24514-24530

MDPI

Access to resources Recommend Favorite